Kathren McCarty, DPM
Podiatrist · San Antonio, TXNPI 1154505089
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,526 of the $3,243 with a category attached, or 77.9%. 13 manufacturers reported payments, led by Stryker at 52.9% of the total. Reporting peaked in 2023 at $1,040 and has fallen 54.8% since, to $470 in 2025.
Across 55 payments — averaging $58.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medinc Of Texas$707
- Nvision Biomedical Technologies, Inc.$196
- Treace Medical Concepts, Inc.$165
- Mission Medical Distribution, LLC$144
- Johnson & Johnson$119
- plus $196 from 7 others
Across 7 payments — averaging $10,714 each. An ownership or investment interest held by the physician or an immediate family member.
- Gramercy Extremity Orthopedics LLC$75K
What the payments were for
- Travel & lodging$100%
- Food & beverage$2,52678%
- Education$70722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 36 | $1,716 |
| Medinc Of Texas | 1 | $707 |
| Nvision Biomedical Technologies, Inc. | 1 | $196 |
| Treace Medical Concepts, Inc. | 7 | $165 |
| Mission Medical Distribution, LLC | 1 | $144 |
| Johnson & Johnson | 1 | $119 |
| Organogenesis Inc. | 1 | $102 |
| Bioventus LLC | 2 | $24 |
| IBSA Pharma Inc. | 1 | $18 |
| Kerecis Limited | 1 | $14 |
| Ossdsign USA Incorporated | 1 | $14 |
| Merck | 1 | $12 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOGRAFT$273
- Foot and Ankle$196
- AXSOS$172
- AUGMENT INJECTABLE$157
- HOFFMANN$147
- XARELTO$119
- PuraPly$102
- EASY CLIP$101
- VARIAX$101
How this compares
$3,243 in reported general payments places this provider in the 60th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 16 | $128 |
| Meloxicam | 29 | $117 |
| Methylprednisolone | 17 | $84 |
| Cephalexin | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in San Antonio
- Anna SanchezSan Antonio$72K
- Lee RogersSan Antonio$65K
- Boyd BillsSan Antonio$12K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.